Invesco
SXTC icon

Invesco’s China SXT Pharmaceuticals SXTC Stock Holding History

Invesco’s Portfolio SXTC Stock Details SXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-569
Closed -$137K – 3821
2025
Q4 		$137K Sell
569
-29
-5% -$6.29K ﹤0.01% 3604
2025
Q3 		$141K Buy
+598
New +$148K ﹤0.01% 3629
2019
Q3 		– Hold
0
– -$88K – 3719
2019
Q2 		– Hold
0
– – – 3688

Other funds holding SXTC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco's SXTC Position: Q1 2026 in Review

Invesco sold out of China SXT Pharmaceuticals (SXTC) in Q1 2026, closing a stake of 569 shares — an estimated $137K sold.

Invesco first reported a position in SXTC in Q3 2025 and held it in 2 quarters. The position peaked at $141K in Q3 2025. 4 funds tracked by Wall St. Rank hold SXTC as of Q1 2026.

  • Invesco reported no remaining China SXT Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Invesco sold 569 China SXT Pharmaceuticals shares in Q1 2026, an estimated $137K.
  • Invesco first reported a position in China SXT Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Invesco's China SXT Pharmaceuticals position peaked at $141K in Q3 2025.
  • 4 funds tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.